Clinical Trials Browser

INDUSTRY × Prostatic Neoplasms × Lenalidomide × Clear all

NCT00988208 2018-04-04

Mainsail

Phase 3 Completed

1,059 enrolled 27 charts

Prostatic Neoplasms

NCT00179738 2005-11-23

A Multicenter, Single-Arm, Open-Label, Study to Evaluate the Safety and Efficacy of Single-Agent Lenalidomide (Revlimid, CC-5013) in Subjects With Androgen Independent Prostate Cancer.

Phase 2 Terminated

Prostatic Neoplasms